Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AJ Roboscreen GmbH, a subsidiary of Analytik Jena, is a biotechnology company specializing in the development and commercialization of high-quality diagnostic kits and reagents. The company focuses on molecular diagnostics and protein analysis, particularly for neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as infectious diseases like Hepatitis B. Their product portfolio includes standardized ELISA kits for biomarkers like Amyloid-beta and Tau, and the RoboGene line for nucleic acid purification and detection. AJ Roboscreen provides automated solutions for clinical diagnostics and research, leveraging its expertise in monoclonal antibody development and assay validation. The company is based in Leipzig, Germany, and operates under ISO 13485 quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AJ Roboscreen.